Direkt zum Inhalt
Merck
  • Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport.

Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport.

American journal of physiology. Heart and circulatory physiology (2003-03-08)
Mirian M da Silva, Adriano Sartori, Eduardo Belisle, Alicia J Kowaltowski
ZUSAMMENFASSUNG

Ischemic preconditioning, or the protective effect of short ischemic episodes on a longer, potentially injurious, ischemic period, is prevented by antagonists of mitochondrial ATP-sensitive K+ channels (mitoKATP) and involves changes in mitochondrial energy metabolism and reactive oxygen release after ischemia. However, the effects of ischemic preconditioning itself on mitochondria are still poorly understood. We determined the effects of ischemic preconditioning on isolated heart mitochondria and found that two brief (5 min) ischemic episodes are sufficient to induce a small but significant decrease ( approximately 25%) in mitochondrial NADH-supported respiration. Preconditioning also increased mitochondrial H2O2 release, an effect related to respiratory inhibition, because it is not observed in the presence of succinate plus rotenone and can be mimicked by chemically inhibiting complex I in the presence of NADH-linked substrates. In addition, preconditioned mitochondria presented more substantial ATP-sensitive K+ transport, indicative of higher mitoKATP activity. Thus we directly demonstrate that preconditioning leads to mitochondrial respiratory inhibition in the presence of NADH-linked substrates, increased reactive oxygen release, and activation of mitoKATP.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Peroxidase aus Meerrettich, Type I, essentially salt-free, lyophilized powder, ≥50 units/mg solid (using pyrogallol)